WallStSmart
ARCT

Arcturus Therapeutics Holdings Inc

NASDAQ: ARCT · HEALTHCARE · BIOTECHNOLOGY

$8.40
-5.30% today

Updated 2026-04-29

Market cap
$238.75M
P/E ratio
P/S ratio
2.91x
EPS (TTM)
$-2.40
Dividend yield
52W range
$6 – $24
Volume
0.5M

Arcturus Therapeutics Holdings Inc (ARCT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.36M$-1.58M$-7.35M$-28.33M$-18.15M$-19.24M$-460000.00$-20.76M$-6.45M$-42.86M$-135.04M$31.99M$-18.10M$-59.75M$-74.27M
Capital expenditures$24000.00$0.00$39000.00$79000.00$181000.00$74000.00$251000.00$1.48M$818000.00$1.74M$3.41M$7.73M$2.90M$648000.00$230000.00
Depreciation$6000.00$7000.00$8000.00$31000.00$51000.00$61000.00$410000.00$582000.00$684000.00$882000.00$1.19M$1.53M$2.96M$3.54M
Stock-based comp$1.55M$26000.00$1.54M$4.09M$2.37M$2.50M$2.17M$1.26M$1.98M$6.76M$28.91M$30.61M$34.65M$37.99M$25.41M
Free cash flow$-2.38M$-1.58M$-7.39M$-28.41M$-18.33M$-19.32M$-711000.00$-22.24M$-7.26M$-44.60M$-138.45M$24.27M$-21.00M$-60.40M$-74.50M
Investing cash flow$-1.04M$1.03M$-28.05M$8.41M$-33.84M$4.88M$10.36M$22.13M$-818000.00$-1.74M$-3.41M$-7.73M$-2.90M$-648000.00
Financing cash flow$2.62M$601000.00$57.40M$66.47M$66.47M$6000.00$7.00M$10.20M$41.91M$436.14M$48.02M$-2.86M$-24.09M$5.42M
Dividends paid
Share repurchases
Debt repayment
Net change in cash$34.64M$391.54M$-90.43M